A call to solve the controversy on omega-3FAs trials - PACE-CME

A call to solve the controversy on omegaFAs trials

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

Renal denervation as option for patients with hypertension despite medications
Renal denervation as option for patients with hypertension despite medications
ACC.21
Renal denervation as option for patients with hypertension despite medications
- Prof. Ajay Kirtane, MD
No difference in clinical outcomes with 81 mg vs. 325 mg aspirin in established CVD
No difference in clinical outcomes with 81 mg vs. 325 mg aspirin in established CVD
ACC.21
No difference in clinical outcomes with 81 mg vs. 325 mg aspirin in established CVD
- William Schuyler Jones, MD
Possible substitution of aspirin by P2Y12 inhibitor monotherapy one year after PCI
Possible substitution of aspirin by P2Y12 inhibitor monotherapy one year after PCI
ACC.21
Possible substitution of aspirin by P2Y12 inhibitor monotherapy one year after PCI
- Prof. Freek Verheugt, MD
12-Months follow up of rapid hs -TnT protocol in ACS suspected patients
12-Months follow up of rapid hs -TnT protocol in ACS suspected patients
ACC.21
12-Months follow up of rapid hs -TnT protocol in ACS suspected patients
- Prof. Derek Chew